“Buyout firm Bain Capital has reached an agreement to buy pharmaceutical joint-venture of Dutch chemicals firm Royal DSM NV and China’s Sinochem Group,” reported Bloomberg. “Singapore-based DSP develops and sells antibiotics, statins and anti-fungals as well as pharmaceutical ingredients, according to its website. It has manufacturing sites in countries from China and India to Egypt, the Netherlands and the U.S.”

AZB & Partners advised Bain Capital Private Equity led by a team of partners Nandita Govind and Anisha Shridhar and lawyers Ananya Thakral and Rohit Dutta.

Primary jurisdiction of deal: Singapore.

2018-06-29

Deal value: Rs 4600 crore ($681m)

{incomplete}